Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Courtney M.P. Hollowell"'
Publikováno v:
Urology Case Reports, Vol 28, Iss , Pp - (2020)
Cutaneous metastases of genitourinary malignancies are an extremely rare phenomenon. Few cases of skin metastasis from urothelial carcinoma of the bladder have been reported. We report a case of 71-year-old female with primary bladder transitional ce
Externí odkaz:
https://doaj.org/article/b7d35f28b7b146e98e77d899306d80d6
Autor:
Jillian R. Scambia, Lindsay Lombardo, Mark A. Wille, Patricia Vidal, Courtney M.P. Hollowell, Traci P. Beck
Publikováno v:
Urology Case Reports, Vol 17, Iss C, Pp 106-108 (2018)
Externí odkaz:
https://doaj.org/article/572ed6395598471da4b55d36ab6a3949
Publikováno v:
Therapeutic Advances in Urology, Vol 5 (2013)
Background: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth regulatory proteins. While most oligos have targeted growth factors or their receptors, others have been directed
Externí odkaz:
https://doaj.org/article/adffa41532a34197ab67071c89d45f6e
Publikováno v:
Therapeutic Advances in Urology, Vol 3 (2011)
Background and methods: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth stimulatory gene products. While most oligos have targeted growth factors or their receptors, others h
Externí odkaz:
https://doaj.org/article/4e808a7e84bf49808fb4f1b5c809e251
Autor:
Rick A. Kittles, Chad Achenbach, Elodi Dielubanza, Yaw Nyame, Courtney M.P. Hollowell, David A. Klein, Iman K. Martin, Ramona Bhatia, Adam B. Murphy
Background: HIV-infected (HIV+) men face cancer treatment disparities that impact outcome. Prostate cancer treatment and treatment appropriateness in HIV+ men are unknown.Methods: We used electronic chart review to conduct a retrospective cohort stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08102e39fe37bb1465c44fb37bb0be0a
https://doi.org/10.1158/1055-9965.c.6514780.v1
https://doi.org/10.1158/1055-9965.c.6514780.v1
Autor:
Rick A. Kittles, Chad Achenbach, Elodi Dielubanza, Yaw Nyame, Courtney M.P. Hollowell, David A. Klein, Iman K. Martin, Ramona Bhatia, Adam B. Murphy
Supplemental Table 1: National Comprehensive Cancer Network guidelines for risk-appropriate therapy for prostate cancer. We have described appropriate treatments for low, intermediate, high, and very high risk categories, along with metastatic diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d623c97ebde8990c69c71d10c01d74b
https://doi.org/10.1158/1055-9965.22435180
https://doi.org/10.1158/1055-9965.22435180
Autor:
Heidy Wang, Shoujin Wu, Adam B. Murphy, Michael R. Abern, Patrice King-Lee, Patricia Vidal, Lisa K. Sharp, Roohollah Sharifi, Karen Ferrer, Marlene Gallegos, Carol Estwing Ferrans, Li Liu, Marin Sekosan, Courtney M.P. Hollowell, Andre Kajdacsy-Balla, Peter H. Gann
Publikováno v:
Journal of Clinical Oncology. 39:1660-1670
PURPOSE The Genomic Prostate Score (GPS), performed on biopsy tissue, predicts adverse outcome in prostate cancer (PCa) and has shown promise for improving patient selection for active surveillance (AS). However, its impact on treatment choice in hig
Autor:
Edward M. Schaeffer, Courtney M.P. Hollowell, Rilwan Babajide, Adam B. Murphy, Alfreda Holloway-Beth, Daniel P. Dalton, Oluwarotimi Nettey, Samuel Carbunaru, Tiffany McDowell, Karriem S. Watson, Peter H. Gann, Josef Ben Levi, James Stinson, Le’Andre Moore, Marcus Murray, Rick A. Kittles
Publikováno v:
J Urol
PURPOSE: The Prostate Health Index is validated for prostate cancer detection but has not been well validated for Gleason grade group 2-5 prostate cancer detection in Black men. We hypothesize that the Prostate Health Index has greater accuracy than
Autor:
Courtney M.P. Hollowell, Joshua A. Broghammer, Allen F. Morey, Lesley Souter, Maxim J. McKibben
Publikováno v:
Journal of Urology. 205:30-35
The authors of this guideline reviewed the urologic trauma literature to guide clinicians in the appropriate methods of evaluation and management of genitourinary injuries.The Panel amended the Guideline in 2020 to reflect additional literature publi
Autor:
Matthew Houlihan, Patricia Vidal, Ryan Powers, Stephen D. Hurley, Mathew Q. Fakhoury, Antoine M. Ghorayeb, Courtney M.P. Hollowell, Kyeezu Kim, Mark A. Wille, Sarah P. Psutka, Vincent L. Freeman
Publikováno v:
Urology. 147:178-185
Objective To determine risk factors for continued smoking following a diagnosis of a genitourinary (GU) malignancy. Smoking is a well established risk factor in the development of cancers involving the GU tract. Unfortunately, a large percentage of p